Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition

Details for Australian Patent Application No. 2005313311 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Terpstra, Jan-Willem; Van Scharrenburg, Gustaaf J. M.; Hesselink, Mayke B.; McCreary, Andrew C.; Stoit, Axel; Pras-Raves, Maria L.; Van Vliet, Bernard J.; Kruse, Cornelis G.; Feenstra, Roelof W.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005313311

PCT Pub. Number WO2006/061378

Priority 04106394.2 08.12.04 EP; 60/634,074 08.12.04 US

Filing date 6 December 2005

Wipo publication date 15 June 2006

International Classifications

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/061378 Priority application(s): WO2006/061378

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313312-Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition

2005313309-Method and arrangement for increasing safety when handling a wheel